Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [470]

Breast cancer heterogeneity no barrier to predictive testing

Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland

Breast cancer heterogeneity no barrier to predictive testing ( Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )

Single cell sequencing techniques in early and late breast cancer

Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA

Single cell sequencing techniques in early and late breast cancer ( Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA )

Measurement variation influences gene expression profiles of breast cancer

Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA

Measurement variation influences gene expression profiles of breast cancer ( Dr Rosanna Lau - MD Anderson Cancer Center, Houston, TX, USA )

Genetic alterations in postmenopausal women with hormone receptor-positive...

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium

Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )

Gene expression test distinguishes between breast cancer patients at high or...

Prof Michael Gnant - Medical University of Vienna, Austria

Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence ( Prof Michael Gnant - Medical University of Vienna, Austria )

The role of physicians and researchers in the medical community

Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller

The role of physicians and researchers in the medical community ( Dr John Mendelsohn, Dr Richard Schilsky and Dr Richard Buller )

Closing the cancer divide: Implementing the diagonal approach

Dr Felicia Knaul - Harvard Medical School, Boston, USA

Closing the cancer divide: Implementing the diagonal approach ( Dr Felicia Knaul - Harvard Medical School, Boston, USA )

Analysing the efficacy of treatment through Response Evaluation Criteria in...

Dr Yves Menu – Saint Antoine Hospital, Paris, France

Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )

Personalised cancer medicine and research: Today’s best practice

Prof José Baselga - Massachusetts General Hospital, Boston, USA

Personalised cancer medicine and research: Today’s best practice ( Prof José Baselga - Massachusetts General Hospital, Boston, USA )

Identifying drug sensitivity and resistance in acute myeloid leukaemia

Dr Mark Frattini – Memorial Sloan-Kettering Cancer Center, New York, USA

Identifying drug sensitivity and resistance in acute myeloid leukaemia ( Dr Mark Frattini – Memorial Sloan-Kettering Cancer Center, New York, USA )

Mouse models and proteomics tackling acute lymphoblastic leukaemia

Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland

Mouse models and proteomics tackling acute lymphoblastic leukaemia ( Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland )

Assessing iron overload and toxicity

Prof John Porter - University College London, UK

Assessing iron overload and toxicity ( Prof John Porter - University College London, UK )

More from ecancer